Immunome, Inc. (IMNM) stock analysis
IMNM · Immunome, Inc.
Latest recorded price: USD 17.61
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: free cash flow margin -2,890.1%, ROIC -102.5%. The model flags 2 risk signals for this company (2 high severity).